Copyright
©The Author(s) 2022.
World J Clin Cases. Jul 6, 2022; 10(19): 6750-6758
Published online Jul 6, 2022. doi: 10.12998/wjcc.v10.i19.6750
Published online Jul 6, 2022. doi: 10.12998/wjcc.v10.i19.6750
Figure 4 Results of Sanger sequencing and fluorescence in situ hybridization.
A: Sanger sequencing showed identical VHL c.529A>T mutation and fluorescence in situ hybridization analysis showed the loss of 3p in the right kidney clear cell renal cell carcinoma (CCRCC); B: The VHL c.529A>T mutation and loss of 3p in metastatic CCRCC component within the left pheochromocytoma (PCC); C: The left retroperitoneal PCC did not carry VHL c.529A>T mutation and loss of 3p; D: The right normal kidney tissue did not carry VHL c.529A>T mutation and loss of 3p. CCRCC: Clear cell renal cell carcinoma; PCC: Pheochromocytoma.
- Citation: Wen HY, Hou J, Zeng H, Zhou Q, Chen N. Tumor-to-tumor metastasis of clear cell renal cell carcinoma to contralateral synchronous pheochromocytoma: A case report. World J Clin Cases 2022; 10(19): 6750-6758
- URL: https://www.wjgnet.com/2307-8960/full/v10/i19/6750.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i19.6750